Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit

被引:69
作者
Chua, Thea
Moore, Carol L.
Perri, Mary B.
Donabedian, Susan M.
Masch, William [2 ]
Vager, Dora
Davis, Susan L. [3 ]
Lulek, Kaitlin [3 ]
Zimnicki, Benjamin [3 ]
Zervos, Marcus J. [1 ]
机构
[1] Wayne State Univ, Henry Ford Hlth Syst, Sch Med, Detroit, MI 48202 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA
关键词
D O I
10.1128/JCM.00154-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To gain a better understanding of epidemiology of resistance in Staphylococcus aureus, we describe the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. Bloodstream isolates from July 2005 to February 2007 were characterized. Two hundred ten bloodstream isolates from 201 patients were evaluated. Patient characteristics were as follows: median age, 54 years; 56% male; and 71% African-American. Seventy-six percent of infections were health care associated, with 55% being community-onset infections and 21% hospital acquired, and 24% were community associated. The most common sources were skin/wound (25%), central venous catheters (24%), unknown source (20%), and endocarditis (9%). Ninety percent and 5% of isolates had a MIC of vancomycin of <= 1.0 mg/liter, using automated dilution testing and E-test, respectively. Six percent of isolates showed heteroresistance to vancomycin, all occurring with isolates having a vancomycin E-test MIC of >= 1.5 mg/liter. Results of pulsed- field gel electrophoresis showed 17 strain types. The predominant strains were USA100 (104 isolates) and USA300 (74 isolates). Forty-nine percent of the isolates had staphylococcal cassette chromosome mec II, and 56% had agr II. All USA300 isolates were positive for the Panton-Valentine leukocidin toxin genes and agr I. Forty-seven percent of USA300 bloodstream infections were health care associated (35% community onset and 12% hospital onset). USA300 strains were more common in injection drug users with skin/wound as the predominant source of infection. Thirty percent of the USA100 strains were closely related to vancomycin-resistant Staphylococcus aureus isolates. The results of this study show that vancomycin MICs using automated dilution testing with Vitek-2 and E-test were highly discordant. Most methicillin-resistant S. aureus strains causing bacteremia are health care associated, commonly have MICs of vancomycin that are high within the susceptible range are not detected by routine automated dilution testing, and have significant diversity of molecular characteristics. USA100 strains that are closely related to vancomycin-resistant S. aureus (VRSA) isolates and USA300 strains are common as causes of both hospital and community-onset infection. Infection control measures should focus not only on prevention of the spread of community strains in the hospital but also prevention of the spread of hospital strains associated with VRSA into the community.
引用
收藏
页码:2345 / 2352
页数:8
相关论文
共 53 条
[21]   Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia [J].
Lina, G ;
Piémont, Y ;
Godail-Gamot, F ;
Bes, M ;
Peter, MO ;
Gauduchon, V ;
Vandenesch, F ;
Etienne, J .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1128-1132
[22]   Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods [J].
Liu, C ;
Chambers, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3040-3045
[23]   Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia [J].
Lodise, TP ;
McKinnon, PS .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) :113-122
[24]   Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 μg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis [J].
Maclayton, Darego O. ;
Suda, Katie J. ;
Coval, Krista A. ;
York, Cynthia B. ;
Garey, Kevin W. .
CLINICAL THERAPEUTICS, 2006, 28 (08) :1208-1216
[25]   Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States:: Establishing a national database [J].
McDougal, LK ;
Steward, CD ;
Killgore, GE ;
Chaitram, JM ;
McAllister, SK ;
Tenover, FC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5113-5120
[26]   Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia [J].
Moise, Pamela A. ;
Smyth, Davida S. ;
El-Fawal, Nadia ;
Robinson, D. Ashley ;
Holden, Patricia N. ;
Forrest, Alan ;
Sakoulas, George .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (01) :85-90
[27]   Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy [J].
Moise-Broder, PA ;
Sakoulas, G ;
Eliopoulos, GM ;
Schentag, JJ ;
Forrest, A ;
Moellering, RC .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1700-1705
[28]   Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community [J].
Okuma, K ;
Iwakawa, K ;
Turnidge, JD ;
Grubb, WB ;
Bell, JM ;
O'Brien, FG ;
Coombs, GW ;
Pearman, JW ;
Tenover, FC ;
Kapi, M ;
Tiensasitorn, C ;
Ito, T ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4289-4294
[29]   An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus [J].
Patel, JB ;
Jevitt, LA ;
Hageman, J ;
McDonald, LC ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :1652-1653
[30]   Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) [J].
Pfaller, MA ;
Jones, RN ;
Doern, GV ;
Kugler, GVDK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1762-1770